Erythropoietin or darbepoetin for patients with malignant disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Erythropoietin or Darbepoetin for Patients With Malignant Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/454451/all/Erythropoietin_or_darbepoetin_for_patients_with_malignant_disease.
Erythropoietin or darbepoetin for patients with malignant disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/454451/all/Erythropoietin_or_darbepoetin_for_patients_with_malignant_disease. Accessed November 3, 2024.
Erythropoietin or darbepoetin for patients with malignant disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/454451/all/Erythropoietin_or_darbepoetin_for_patients_with_malignant_disease
Erythropoietin or Darbepoetin for Patients With Malignant Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 November 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/454451/all/Erythropoietin_or_darbepoetin_for_patients_with_malignant_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Erythropoietin or darbepoetin for patients with malignant disease
ID - 454451
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/454451/all/Erythropoietin_or_darbepoetin_for_patients_with_malignant_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -